Home › Funds › XCELSIOR ADVISOR PARTNERS LLC › IOVA

XCELSIOR ADVISOR PARTNERS LLC position in IOVA

IOVANCE BIOTHERAPEUTICS INC · Health Care

XCELSIOR ADVISOR PARTNERS LLC reported holding 1,841,485 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$27.3M, representing 1.90% of its reported portfolio and ranking #5 among its reported holdings. XCELSIOR ADVISOR PARTNERS LLC has disclosed IOVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.84M sh
Reported value held$27.29M
Portfolio Weight1.90%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How XCELSIOR ADVISOR PARTNERS LLC's IOVA position evolved

XCELSIOR ADVISOR PARTNERS LLC first disclosed a stake in IOVA in Q4 2025 at 15,150 shares (US$41K). The position peaked in Q3 2026 at 1,841,485 shares, worth US$27.3M. Across 4 filings, XCELSIOR ADVISOR PARTNERS LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,841,485 shares valued at US$27.3M — an increase of 57,561 shares quarter over quarter.. Notable position changes include a 12507% increase in Q2 2026 (shares rose 256% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 15.15K $41.36K New
Q1 2026 14.15K $49.67K Reduce
Q2 2026 1.78M $7.42M Add
Q3 2026 1.84M $27.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IOVA and 13F data

IOVA (IOVANCE BIOTHERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Rhenman & Partners Asset Management AB (US$37.1M), Orion Investment Co (US$30.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IOVA

All IOVA fund holders →

FAQ

How long has XCELSIOR ADVISOR PARTNERS LLC held IOVA?

XCELSIOR ADVISOR PARTNERS LLC has disclosed IOVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is XCELSIOR ADVISOR PARTNERS LLC's current position in IOVA?

As of Q3 2026, XCELSIOR ADVISOR PARTNERS LLC holds 1.84M shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), valued at $27.29M, representing 1.90% of its reported portfolio and ranking #5.

Has XCELSIOR ADVISOR PARTNERS LLC been buying or selling IOVA?

In the latest 13F filing (Q3 2026), XCELSIOR ADVISOR PARTNERS LLC increased its position in IOVA. The position peaked in Q3 2026 at 1.84M shares.

Which other funds hold IOVA?

Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Rhenman & Partners Asset Management AB, Orion Investment Co, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.